Document is current
Any future updates will be listed below
-
Authors
Sighinolfi, Giovanna
Grandi, Giovanni
Barbieri, Elena
Venturelli, Marta
Piombino, Claudia https://orcid.org/0000-0002-7224-4536
Melotti, Chiara
Lippi Bruni, Rebecca
Costantini Cuoghi, Riccardo
D’Amico, Roberto
Lambertini, Matteo https://orcid.org/0000-0003-1797-5296
Peccatori, Fedro A. https://orcid.org/0000-0001-8227-8740
Tenedini, Elena
Dominici, Massimo https://orcid.org/0000-0002-4007-1503
Cortesi, Laura
La Marca, Antonio
Toss, Angela https://orcid.org/0000-0002-1854-6701
-
Funding
Funding for this research was provided by:
Ricerca Finalizzata 2018, Bando Giovane Ricercatore
- License Information
-
More Information
Article History
Received: 14 March 2024
Accepted: 24 February 2025
First Online: 8 March 2025
Competing interests
: G.S., G.G., M.V., C.P., C.M., R.L.B., R.C.C., R.D., F.A.P., and M.D. reported no conflicts of interest. E.B. reported travel grants from Lilly, Novartis, Pfizer, MSD, AstraZeneca, Gilead, and Daiichi Sankyo, all outside the submitted work. M.L. reported advisory role for Roche, Lilly, Novartis, AstraZeneca, Pfizer, Seagen, Gilead, MSD, Exact Sciences; speaker honoraria from Roche, Lilly, Novartis, Pfizer, Sandoz, Libbs, Daiichi Sankyo, Takeda, Knight, Ipsen, AstraZeneca; travel grants from Gilead, Daiichi Sankyo, Roche and a research grant (to his Institution) from Gilead, all outside the submitted work. E.T. reported travel grants and speaker honoraria from MSD and SOPHiA GENETICS, all outside the submitted work. L.C. reported personal fees from AstraZeneca, Pfizer, Novartis, Gilead, and Clovis and grants from MSD outside the submitted work. A.L.M. reported grants from Merck, Ferring Pharmaceuticals, MSD, IBSA MSD, Roche Diagnostics, Beckmann Coulter, and TEVA, all outside the submitted work. A.T. reported conflicts of interest with Lilly, Novartis, Pfizer, AstraZeneca, MSD, Seagen, Gilead, and Daiichi Sankyo, all outside the submitted work.
